Search the database for deliberate release of GM medicinal products
Displaying 1 - 1 of 1
|EU record number
|Company / Sponsor
|Only notified under the "contained use" procedure. Dossier submitted on 09/06/1998.
|A phase II, multi-center, open label, randomized study to evaluate biodistribution and transmission, effectiveness and safety of two treatment regimens of Ad5CMV-p53 administered by intra-tumoral injections in 40 evaluable patients with advanced squamous